Management will discuss the advantages of the Company’s 3S TCRs across a wide range of modalities, including TCR-engineered T cell (TCR-T) therapies, TCR-guided T cell engager therapies (TCR-TCE), and ...
The presented posters “ Advancing a multi-dimension KRAS mutation-specific T cell receptor (TCR) library with a 3S TCR targeting the G12D mutation to address large global patient populations ” and “ ...
Banco Comercial Português, S.A. informs about the ruling of the Competition, Regulation and Supervision Court Attachment 2024 09 20 Decisão TCRS_EN ...